It can’t seem to hold above 50 cents per share. But if there weren’t enormous potential they’d never have been able to convince Chiesi to invest. I’m convinced there will be a trigger that moves the stock upward and never looks back. Test results, FDA approval, a licensing agreement. Meanwhile it certainly takes fortitude to hold on during the dips.